Business Description
Vanta Bioscience Ltd
ISIN : INE695X01011
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.18 | |||||
Debt-to-Equity | 4.01 | |||||
Debt-to-EBITDA | 42.95 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.14 | |||||
Beneish M-Score | -0.54 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1 | |||||
3-Year EBITDA Growth Rate | -28.6 | |||||
3-Year FCF Growth Rate | 63.8 | |||||
3-Year Book Growth Rate | -14 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 2.97 | |||||
9-Day RSI | 12.58 | |||||
14-Day RSI | 21.79 | |||||
6-1 Month Momentum % | -27.83 | |||||
12-1 Month Momentum % | 20.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.75 | |||||
Quick Ratio | 0.42 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 3681.02 | |||||
Days Sales Outstanding | 89.86 | |||||
Days Payable | 2295.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -35.86 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 92.59 | |||||
Operating Margin % | -32.75 | |||||
Net Margin % | -23.82 | |||||
FCF Margin % | -7.41 | |||||
ROE % | -13.98 | |||||
ROA % | -2.73 | |||||
ROIC % | -3.73 | |||||
3-Year ROIIC % | -21.02 | |||||
ROC (Joel Greenblatt) % | -8.97 | |||||
ROCE % | -4.72 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.74 | |||||
PB Ratio | 1.75 | |||||
Price-to-Operating-Cash-Flow | 9.91 | |||||
EV-to-EBIT | -28.4 | |||||
EV-to-EBITDA | 61.59 | |||||
EV-to-Revenue | 8.99 | |||||
EV-to-FCF | -121.28 | |||||
Earnings Yield (Greenblatt) % | -3.52 | |||||
FCF Yield % | -2.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vanta Bioscience Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 97.229 | ||
EPS (TTM) (₹) | -3.67 | ||
Beta | 0.56 | ||
Volatility % | 107.48 | ||
14-Day RSI | 21.79 | ||
14-Day ATR (₹) | 1.33509 | ||
20-Day SMA (₹) | 46.984 | ||
12-1 Month Momentum % | 20.75 | ||
52-Week Range (₹) | 37 - 101.64 | ||
Shares Outstanding (Mil) | 6.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vanta Bioscience Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vanta Bioscience Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Vanta Bioscience Ltd Frequently Asked Questions
What is Vanta Bioscience Ltd(BOM:540729)'s stock price today?
When is next earnings date of Vanta Bioscience Ltd(BOM:540729)?
Does Vanta Bioscience Ltd(BOM:540729) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |